The impact of coronavirus disease 2019 (COVID-19) response on central-line-associated bloodstream infections and blood culture contamination rates at a tertiary-care center in the Greater Detroit area

Infect Control Hosp Epidemiol. 2021 Aug;42(8):997-1000. doi: 10.1017/ice.2020.1335. Epub 2020 Nov 20.

Abstract

We conducted a comparative retrospective study to quantify the impact of coronavirus disease 2019 (COVID-19) on patient safety. We found a statistically significant increase in central-line-associated bloodstream infections and blood culture contamination rates during the pandemic. Increased length of stay and mortality were also observed during the COVID-19 pandemic.

MeSH terms

  • Blood Culture
  • COVID-19*
  • Humans
  • Pandemics
  • Retrospective Studies
  • SARS-CoV-2
  • Sepsis*